Skip to search.
 Dow Down0.74% Nasdaq Down0.43%

Merck & Co. Inc. (MRK)

-NYSE

46.91 Down 0.37(0.78%) 9:58AM EDT - Nasdaq Real Time Price

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 30, 2013Dec 30, 2012Sep 29, 2012Jun 29, 2012
Total Revenue 10,671,000   11,737,000   11,489,000   12,310,000  
Cost of Revenue3,959,000  4,160,000  4,136,000  4,113,000  
Gross Profit 6,712,000   7,577,000   7,353,000   8,197,000  
Operating Expenses
Research Development1,907,000  2,224,000  1,918,000  2,164,000  
Selling General and Administrative2,987,000  3,390,000  3,064,000  3,248,000  
Non Recurring119,000  191,000  110,000  144,000  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss 1,699,000   1,772,000   2,261,000   2,641,000  
Income from Continuing Operations
Total Other Income/Expenses Net(282,000)(670,000)(199,000)(105,000)
Earnings Before Interest And Taxes1,550,000  1,334,000  2,219,000  2,679,000  
Interest Expense -   -   -   -  
Income Before Tax1,550,000  1,334,000  2,219,000  2,679,000  
Income Tax Expense(66,000)385,000  456,000  859,000  
Minority Interest(23,000)(42,000)(33,000)(27,000)
Net Income From Continuing Ops1,726,000  1,139,000  1,887,000  1,936,000  
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income 1,593,000   907,000   1,730,000   1,793,000  
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares 1,593,000   907,000   1,730,000   1,793,000  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.